 According to the "Times", Australian researcher Michael Ashenden testified that Armstrong's levels rose and fell, consistent with a series of injections during the 1999 Tour.Ashenden, a paid expert retained by SCA Promotions, told arbitrators the results painted a "compelling picture" that the world's most famous cyclist "used EPO in the '99 Tour.